NCT03437785 - Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

January 16, 2018

Primary Completion Date

October 12, 2018

Study Completion Date

October 12, 2018

Conditions

Gastritis

Interventions

DRUG

CKD-495 75mg

CKD-495 75mg Tab.

DRUG

CKD-495 150mg

CKD-495 150mg Tab.

DRUG

Artemisiae argyi folium 95% ethanol ext.(20→1) 60mg

Artemisiae argyi folium 95% ethanol ext.(20→1) 60mg Tab.

DRUG

Rebamipide 100mg

Rebamipide 100mg Tab.

DRUG

Placebo of the CKD-495 75mg

Placebo of the CKD-495 75mg Tab.

DRUG

Placebo of the CKD-495 150mg

Placebo of the CKD-495 150mg Tab.

DRUG

Placebo of Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg

Placebo of Artemisia Herb 95% Ethanol Soft Ext.(20→1) 60mg Tab.

DRUG

Placebo of the Rebamipide 100mg

Placebo of the Rebamipide 100mg Tab

Trial Locations (16)

501-757

Chonnam National University Hospital, Gwangju

Unknown

Keimyung University Dongsan Medical Center, Daegu

Kyungpook National University Hospital, Daegu

Busan National University Hospital, Busan

Inje University Busan Paik Hospital, Busan

Hallym University Chuncheon Seonsim Hospital, Chuncheon

Yeungnam University Medical Center, Daegu

Wonkwang University Hospital, Iksan

Jeju National University Hospital, Jeju City

Chonbuk National University Hospital, Jeonju

Seoul National University Bundang Hospital, Seongnam

Hanyang University Hospital, Seoul

Korea University Guro Hospital, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul

602-702

Kosin University Gospel Hospital, Busan